CORRELATION OF BLOOD-LEVELS OF SOLUBLE VASCULAR CELL-ADHESION MOLECULE-1 WITH DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND VASCULITIS

被引:0
|
作者
JANSSEN, BA [1 ]
LUQMANI, RA [1 ]
GORDON, C [1 ]
HEMINGWAY, IH [1 ]
BACON, PA [1 ]
GEARING, AJH [1 ]
EMERY, P [1 ]
机构
[1] BRITISH BIOTECHNOL LTD, OXFORD OX4 5LY, ENGLAND
来源
BRITISH JOURNAL OF RHEUMATOLOGY | 1994年 / 33卷 / 12期
关键词
SOLUBLE ADHESION MOLECULES; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Levels of soluble adhesion molecules have been shown to reflect their cell surface expression in vitro, and thus may provide a useful surrogate marker of surface expression at inflammatory sites. In patients with SLE and vasculitis, serum levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-Selectin were determined by ELISA during different stages of disease activity. Levels of soluble(s) VCAM-1 correlated with disease activity in patients with SLE, being significantly higher during active compared with inactive disease (P = 0.003), and normalizing with clinical remission. By contrast, in patients with vasculitis, although sVCAM-1 levels were elevated in active disease, they fell but did not normalize in inactive disease, suggesting that treatment may be suppressing the clinical manifestations rather than targeting the underlying pathogenic mechanism. Soluble ICAM-1 and E-Selectin levels did not reflect disease activity in either SLE or vasculitis.
引用
收藏
页码:1112 / 1116
页数:5
相关论文
共 50 条
  • [41] THE MONITORING OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS SHOWS NO CORRELATION BETWEEN SUPPRESSOR-CELL FUNCTION AND DISEASE-ACTIVITY
    RAUTENSTRAUCH, H
    FRANK, F
    SAAL, JG
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1985, 44 (03): : 133 - 136
  • [42] Vascular Cell Adhesion Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin in Systemic Lupus Erythematosus.
    Kiani, Adnan
    Fang, Hong
    Wu, Tianfu
    Magder, Laurence S.
    Mohan, Chandra
    Petri, Michelle
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S231 - S232
  • [43] EXPRESSION AND FUNCTIONAL-CHARACTERIZATION OF A SOLUBLE FORM OF VASCULAR CELL-ADHESION MOLECULE-1
    LOBB, R
    CHIROSSO, G
    LEONE, D
    ROSA, M
    NEWMAN, B
    LUHOWSKYJ, S
    OSBORN, L
    SCHIFFER, S
    BENJAMIN, C
    DOUGAS, I
    HESSION, C
    CHOW, PC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (03) : 1498 - 1504
  • [44] VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1) EXPRESSION IN MURINE LUPUS NEPHRITIS
    WUTHRICH, RP
    SNYDER, TL
    KIDNEY INTERNATIONAL, 1992, 42 (04) : 903 - 914
  • [45] Elevated Urinary and Blood Vascular Cell Adhesion Molecule-1 as Potential Biomarkers for Active Systemic Lupus Erythematosus: A Meta-analysis
    Xia, Yuan-Rui
    Mao, Yan-Mei
    Wang, Jun-Ping
    Li, Qing-Ru
    Fan, Yin-Guang
    Pan, Hai-Feng
    Ye, Dong-Qing
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (46) : 5998 - 6006
  • [46] THE C1Q BINDING IN SYSTEMIC LUPUS-ERYTHEMATOSUS - DISCORDANCE WITH DISEASE-ACTIVITY
    INMAN, RD
    FONG, JKK
    PUSSELL, BA
    RYAN, PJ
    HUGHES, GRV
    ARTHRITIS AND RHEUMATISM, 1980, 23 (06): : 694 - 695
  • [47] Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in asymptomatic carriers of hepatitis C virus
    Fukuda, Y
    Nakano, I
    Katano, Y
    Marui, A
    Hayakawa, T
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1998, 26 (06) : 313 - 318
  • [48] SOLUBLE INTERLEUKIN-2 RECEPTOR AS A PARAMETER FOR DISEASE-ACTIVITY IN THE SERUM OF SYSTEMIC AND DISCOID LUPUS-ERYTHEMATOSUS
    BLUM, C
    ZILLIKENS, D
    TONY, HP
    HARTMANN, AA
    BURG, G
    HAUTARZT, 1993, 44 (05): : 290 - 295
  • [49] SERUM SOLUBLE INTERLEUKIN-2 RECEPTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS - EFFECTS OF DISEASE-ACTIVITY AND INFECTION
    WONG, KL
    WONG, RPO
    ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (10) : 706 - 709
  • [50] SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR, SOLUBLE CD8 AND SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 LEVELS IN CROHNS-DISEASE, CELIAC-DISEASE AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    SRIVASTAVA, MD
    ROSSI, TM
    LEBENTHAL, E
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1995, 87 (01) : 21 - 26